GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Thursday reported a loss of $54.6 million in its fourth quarter.
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of $1.04. Losses, adjusted for non-recurring costs, came to 43 cents per share.
The biopharmaceutical company posted revenue of $148.7 million in the period.
For the year, the company reported profit of $52.6 million, or 93 cents per share. Revenue was reported as $742.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EBS at https://www.zacks.com/ap/EBS
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
